Medicare Enrolled
Dr. Raymond Esper, MD
Hematology · Fort Myers, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Esper from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Esper? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Esper
Dr. Raymond Esper is a hematology in Fort Myers, FL, with 16 years in practice. Based on federal Medicare data, Dr. Esper performed 318,346 Medicare services across 5,349 unique beneficiaries.
Between the years covered by Open Payments, Dr. Esper received a total of $29,378 from 99 pharmaceutical and/or device companies across 1365 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Esper is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice▲ Top 8% volume in FL$ $29,378 industry payments
Medicare Practice Summary
Medicare Utilization ↗318,346
Medicare services
Top 8% in FL for hematology
5,349
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~19,897 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 106,590 | $0 | $4 |
| Iron infusion (Injectafer) | 33,000 | $1 | $3 |
| Epoetin alfa injection (Procrit) for anemia | 25,590 | $6 | $23 |
| Azacitidine chemotherapy injection | 24,300 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 23,280 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 19,400 | $43 | $137 |
| Nivolumab injection (Opdivo) | 16,420 | $24 | $72 |
| Injection, luspatercept-aamt, 0.25 mg | 16,200 | $31 | $89 |
| Daratumumab injection (Darzalex) | 8,460 | $38 | $110 |
| Anti-nausea injection (aprepitant) | 7,800 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 6,960 | $18 | $51 |
| Iron sucrose injection (Venofer) | 5,000 | $0 | $5 |
| Dexamethasone injection (steroid) | 2,904 | $0 | $3 |
| Complete blood count (CBC) with differential | 2,534 | $8 | $29 |
| Immune globulin infusion (Gammagard) | 2,420 | $36 | $108 |
| Blood draw (venipuncture) | 2,328 | $8 | $9 |
| Injection, bortezomib, 0.1 mg | 2,170 | $4 | $113 |
| Infliximab infusion (Remicade) | 2,040 | $27 | $124 |
| Drug injection, under skin or into muscle | 1,134 | $11 | $69 |
| Red blood count automated, with additional calculations | 1,100 | $5 | $20 |
| Office visit, established patient (30-39 min) | 910 | $100 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 900 | $1 | $28 |
| Anti-nausea injection (ondansetron/Zofran) | 684 | $0 | $9 |
| Office visit, established patient (20-29 min) | 615 | $68 | $239 |
| Injection of additional new drug or substance into vein | 549 | $12 | $61 |
| Office visit, established patient, complex (40-54 min) | 537 | $143 | $474 |
| Administration of chemotherapy into vein, 1 hour or less | 528 | $103 | $378 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 447 | $3 | $205 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 430 | $49 | $189 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 368 | $1 | $6 |
| Injection, zoledronic acid, 1 mg | 252 | $7 | $69 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 231 | $57 | $206 |
| Administration of chemotherapy into vein, each additional hour | 223 | $23 | $79 |
| Injection, carboplatin, 50 mg | 181 | $2 | $41 |
| Infusion into a vein for hydration, each additional hour | 174 | $10 | $42 |
| Injection, diphenhydramine hcl, up to 50 mg | 171 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 148 | $23 | $84 |
| Injection, fluorouracil, 500 mg | 137 | $2 | $7 |
| Administration of additional new drug or substance into vein, 1 hour or less | 134 | $52 | $178 |
| Injection of drug or substance into vein | 131 | $29 | $156 |
| Infusion, normal saline solution , 1000 cc | 122 | $2 | $7 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 100 | $3 | $11 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 81 | $16 | $56 |
| New patient office visit (30-44 min) | 70 | $86 | $298 |
| Injection, magnesium sulfate, per 500 mg | 70 | $1 | $2 |
| Infusion into a vein for hydration, 31-60 minutes | 67 | $25 | $156 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 64 | $17 | $59 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 62 | $25 | $89 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 58 | $134 | $562 |
| Drawing of blood for a medical problem | 46 | $72 | $277 |
| New patient office visit (45-59 min) | 46 | $125 | $453 |
| Automated urinalysis | 39 | $2 | $8 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 33 | $4 | $15 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 31 | $1 | $7 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 26 | $132 | $467 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 21 | $117 | $637 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 16 | $15 | $56 |
| Transitional care management services for problem of high complexity | 14 | $223 | $722 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
45.6% high complexity
51.7% medium
2.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$29,378
Total received (2018-2024)
Avg $4,197/year across 7 years
Top 16% in FL for hematology
99
Companies
1,365
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,625 (87.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,445 (11.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$308 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$7,170
2023$5,516
2022$4,130
2021$2,792
2020$3,422
2019$3,356
2018$2,991
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,003
Novartis Pharmaceuticals Corporation
$1,896
Janssen Biotech, Inc.
$1,703
Celgene Corporation
$1,597
Merck Sharp & Dohme LLC
$1,416
E.R. Squibb & Sons, L.L.C.
$1,416
SERVIER PHARMACEUTICALS LLC
$1,392
GENZYME CORPORATION
$1,277
Merck Sharp & Dohme Corporation
$1,197
Incyte Corporation
$956
Genentech USA, Inc.
$900
PFIZER INC.
$821
Astellas Pharma US Inc
$701
Ipsen Biopharmaceuticals, Inc
$659
GlaxoSmithKline, LLC.
$554
Gilead Sciences, Inc.
$552
Daiichi Sankyo Inc.
$506
Agios Pharmaceuticals, Inc.
$480
Seagen Inc.
$477
Puma Biotechnology, Inc.
$459
Amgen Inc.
$441
Rigel Pharmaceuticals, Inc.
$366
ARRAY BIOPHARMA INC
$362
Lilly USA, LLC
$361
JAZZ PHARMACEUTICALS INC.
$354
Regeneron Healthcare Solutions, Inc.
$340
Exelixis Inc.
$318
Takeda Pharmaceuticals U.S.A., Inc.
$317
BeiGene USA, Inc.
$317
NanoString Technologies, Inc.
$290
SOBI, INC
$227
Bayer HealthCare Pharmaceuticals Inc.
$222
Eisai Inc.
$219
Foundation Medicine, Inc.
$199
Genmab U.S., Inc.
$184
Alexion Pharmaceuticals, Inc.
$181
Mirati Therapeutics, Inc.
$166
ADC Therapeutics America, Inc.
$164
Boehringer Ingelheim Pharmaceuticals, Inc.
$149
Stemline Therapeutics Inc.
$146
Kyowa Kirin, Inc.
$143
TAIHO ONCOLOGY, INC.
$142
Pharmacyclics LLC, An AbbVie Company
$134
EMD Serono, Inc.
$128
Sumitomo Pharma America, Inc.
$126
BioMarin Pharmaceutical Inc.
$125
Bayer Healthcare Pharmaceuticals Inc.
$110
Kite Pharma, Inc.
$106
CTI BioPharma Corp.
$104
EISAI INC.
$88
PharmaEssentia USA Corporation
$85
AbbVie Inc.
$77
Adaptive Biotechnologies Corporation
$76
ABBVIE INC.
$74
Pharmacosmos Therapeutics Inc.
$70
Taiho Oncology, Inc.
$67
Pharmacyclics LLC, an AbbVie Company
$67
PUMA BIOTECHNOLOGY, INC.
$65
G1 Therapeutics, Inc.
$65
Immunocore Limited
$61
Dendreon Pharmaceuticals LLC
$60
Alnylam Pharmaceuticals Inc.
$56
Jazz Pharmaceuticals Inc.
$51
Aurobindo Pharma USA, Inc.
$51
Janssen Pharmaceuticals, Inc
$49
Lexicon Pharmaceuticals, Inc.
$47
Epizyme, Inc.,
$47
Helsinn Therapeutics (U.S.), Inc.
$46
Karyopharm Therapeutics Inc.
$46
Acrotech Biopharma LLC
$42
MorphoSys, US Inc.
$41
Heron Therapeutics, Inc.
$40
CSL Behring
$38
Blueprint Medicines Corporation
$38
Sirtex Medical Inc
$37
TerSera Therapeutics LLC
$35
Teva Pharmaceuticals USA, Inc.
$35
Deciphera Pharmaceuticals Inc.
$34
Aveo Pharmaceuticals, Inc.
$33
SUN PHARMACEUTICAL INDUSTRIES INC.
$31
Spectrum Pharmaceuticals Inc.
$25
Veracyte, Inc.
$24
Secura Bio, Inc.
$24
EUSA Pharma (US) LLC
$24
Janssen Scientific Affairs, LLC
$23
Dova Pharmaceuticals
$22
Tempus AI, Inc
$21
Sobi, Inc
$18
Blue Earth Diagnostics Limited
$18
Seattle Genetics, Inc.
$17
GE HealthCare
$16
BIOVERATIV THERAPEUTICS INC.
$14
Horizon Therapeutics plc
$14
INSYS Therapeutics Inc
$12
Octapharma USA, Inc.
$12
Horizon Pharma plc
$12
Sysmex America, Inc.
$11
GE HEALTHCARE
$9
Clovis Oncology, Inc.
$7
Top 3 companies account for 19.1% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · Axumin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Cinvanti · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELOCTATE · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Enhertu · Epkinly · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAZYVA · GILOTRIF · Halaven · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Idelvion · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · KRYSTEXXA · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · Marqibo · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONIVYDE · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Odomzo · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETACRIT · RETEVMO · ROCTAVIAN · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SYNDROS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XN Series · XOSPATA · XPOVIO · XTANDI · Xermelo · Xolair · Xospata · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYKADIA · ZYTIGA · Zevalin · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $9 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
15
Per 100K population
1.9
County median income
$73,099
Nearest hospital
PARK ROYAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Esper is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), and high industry engagement (low-engagement, top 16%), with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Esper experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Esper performed 106,590 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Esper receive payments from pharmaceutical companies?
Yes. Dr. Esper received a total of $29,378 from 99 companies across 1,365 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Esper's costs compare to other hematologys in Fort Myers?
Dr. Esper's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Esper) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Fort Myers
Browse hematologys in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology